ALPS Advisors’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $425K | Sell |
46,080
-14,140
| -23% | -$130K | ﹤0.01% | 726 |
|
|
2025
Q1 | $517K | Sell |
60,220
-8,346
| -12% | -$71.6K | ﹤0.01% | 587 |
|
|
2024
Q4 | $736K | Buy |
68,566
+4,587
| +7% | +$49.3K | ﹤0.01% | 545 |
|
|
2024
Q3 | $363K | Sell |
63,979
-2,070
| -3% | -$11.8K | ﹤0.01% | 791 |
|
|
2024
Q2 | $279K | Buy |
66,049
+8,136
| +14% | +$34.3K | ﹤0.01% | 871 |
|
|
2024
Q1 | $295K | Buy |
57,913
+1,782
| +3% | +$9.07K | ﹤0.01% | 905 |
|
|
2023
Q4 | $523K | Sell |
56,131
-4,320
| -7% | -$40.2K | ﹤0.01% | 600 |
|
|
2023
Q3 | $396K | Buy |
60,451
+1,031
| +2% | +$6.75K | ﹤0.01% | 626 |
|
|
2023
Q2 | $483K | Buy |
59,420
+8,007
| +16% | +$65.1K | ﹤0.01% | 618 |
|
|
2023
Q1 | $441K | Sell |
51,413
-1,511
| -3% | -$12.9K | ﹤0.01% | 603 |
|
|
2022
Q4 | $490K | Buy |
52,924
+10,424
| +25% | +$96.5K | ﹤0.01% | 595 |
|
|
2022
Q3 | $439K | Sell |
42,500
-3,426
| -7% | -$35.4K | ﹤0.01% | 631 |
|
|
2022
Q2 | $460K | Sell |
45,926
-32,360
| -41% | -$324K | ﹤0.01% | 624 |
|
|
2022
Q1 | $964K | Sell |
78,286
-9,686
| -11% | -$119K | 0.01% | 316 |
|
|
2021
Q4 | $1.53M | Buy |
+87,972
| New | +$1.53M | 0.02% | 317 |
|